The latest data from Symphony Health Solutions, released today, indicates a market share (4w rolling average) for Zubsolv of 5.7% (quantity) and of 5.3 (prescriptions). The underlying market continues to show healthy growth rate (4w rolling average), a y/y increase of 10.6% (quantity) and of 10.0% (prescriptions).